These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24370195)

  • 1. Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis.
    Inubushi T; Kawazoe A; Miyauchi M; Yanagisawa S; Subarnbhesaj A; Chanbora C; Ayuningtyas NF; Ishikado A; Tanaka E; Takata T
    Arch Oral Biol; 2014 Feb; 59(2):226-32. PubMed ID: 24370195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis.
    Yamano E; Miyauchi M; Furusyo H; Kawazoe A; Ishikado A; Makino T; Tanne K; Tanaka E; Takata T
    Lab Invest; 2010 Aug; 90(8):1236-46. PubMed ID: 20421871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue.
    Oka H; Miyauchi M; Furusho H; Nishihara T; Takata T
    J Periodontol; 2012 Apr; 83(4):506-13. PubMed ID: 21910594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of novel lactoferrin peptides on LPS-induced alveolar bone destruction in a rat model.
    Yamada S; Chea C; Furusho H; Oda K; Shiba F; Tanimoto K; Tate SI; Miyauchi M; Takata T
    Chem Biol Drug Des; 2024 Jul; 104(1):e14574. PubMed ID: 38958121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis.
    Inubushi T; Kawazoe A; Miyauchi M; Kudo Y; Ao M; Ishikado A; Makino T; Takata T
    J Biol Chem; 2012 Jul; 287(28):23527-36. PubMed ID: 22593578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway.
    Luo XH; Guo LJ; Xie H; Yuan LQ; Wu XP; Zhou HD; Liao EY
    J Bone Miner Res; 2006 Oct; 21(10):1648-56. PubMed ID: 16995820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminothiazoles inhibit osteoclastogenesis and PGE
    Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orally administered liposomal lactoferrin inhibits inflammation-related bone breakdown without interrupting orthodontic tooth movement.
    Kawazoe A; Inubushi T; Miyauchi M; Ishikado A; Tanaka E; Tanne K; Takata T
    J Periodontol; 2013 Oct; 84(10):1454-62. PubMed ID: 23136974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms underlying the inhibitory effects of bovine lactoferrin on osteosarcoma.
    Chea C; Haing S; Miyauchi M; Shrestha M; Imanaka H; Takata T
    Biochem Biophys Res Commun; 2019 Jan; 508(3):946-952. PubMed ID: 30545626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles of TNFR1 in lipopolysaccharide-induced bone loss: dual effects of TNFR1 on bone metabolism via osteoclastogenesis and osteoblast survival.
    Ochi H; Hara Y; Tagawa M; Shinomiya K; Asou Y
    J Orthop Res; 2010 May; 28(5):657-63. PubMed ID: 19890995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of compressive loading and incubation with clodronate on the RANKL/OPG system of human osteoblasts.
    Grimm S; Walter C; Pabst A; Goldschmitt J; Wehrbein H; Jacobs C
    J Orofac Orthop; 2015 Nov; 76(6):531-42. PubMed ID: 26446504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wogonin inhibits osteoclast formation induced by lipopolysaccharide.
    Jang S; Bak EJ; Kim M; Kim JM; Chung WY; Cha JH; Yoo YJ
    Phytother Res; 2010 Jul; 24(7):964-8. PubMed ID: 19998398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoblasts of calvaria induce higher numbers of osteoclasts than osteoblasts from long bone.
    Wan Q; Schoenmaker T; Jansen ID; Bian Z; de Vries TJ; Everts V
    Bone; 2016 May; 86():10-21. PubMed ID: 26921824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis.
    Kanzaki H; Chiba M; Shimizu Y; Mitani H
    J Bone Miner Res; 2002 Feb; 17(2):210-20. PubMed ID: 11811551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sesquiterpene lactone parthenolide blocks lipopolysaccharide-induced osteolysis through the suppression of NF-kappaB activity.
    Yip KH; Zheng MH; Feng HT; Steer JH; Joyce DA; Xu J
    J Bone Miner Res; 2004 Nov; 19(11):1905-16. PubMed ID: 15476591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
    Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
    Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long chain polyunsaturated fatty acids alter membrane-bound RANK-L expression and osteoprotegerin secretion by MC3T3-E1 osteoblast-like cells.
    Poulsen RC; Wolber FM; Moughan PJ; Kruger MC
    Prostaglandins Other Lipid Mediat; 2008 Feb; 85(1-2):42-8. PubMed ID: 18077200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N; Maeda H; Yoshimine Y; Akamine A
    Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.